Table 1. Characteristics of case-control studies on microRNA polymorphisms and CHD risk included in the meta-analysis.
First author | Year | Country/Region | Ethnicity | Source of controls | Case | Control | Genotype distribution | Genotyping methods | Age and sex matched | P for HWEa | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Case | Control | ||||||||||||||
microRNA-146a rs2910164 G>C | CC | GC | GG | CC | GC | GG | |||||||||
Sung JH | 2016 | Korea | Asian | Hospital | 522 | 535 | 203 | 242 | 77 | 202 | 260 | 73 | PCR-RFLP | matched | 0.460 |
Bastami M | 2016 | Iran | Caucasian | NA | 300 | 300 | 34 | 155 | 111 | 22 | 128 | 150 | Taqman | matched | 0.454 |
Huang SL | 2015 | China | Asian | Hospital | 722 | 721 | 266 | 308 | 143 | 237 | 348 | 132 | Taqman | matched | 0.830 |
Xiong XD | 2014 | China | Asian | Hospital | 295 | 283 | 113 | 141 | 41 | 97 | 125 | 61 | PCR-RFLP | unmatched | 0.086 |
Prithiksha R | 2014 | South Africa | Asian | NA | 106 | 100 | 13 | 43 | 50 | 9 | 46 | 45 | PCR-RFLP | matched | 0.569 |
Chen CR | 2014 | China | Asian | Hospital | 919 | 889 | 187 | 463 | 269 | 153 | 435 | 301 | PCR-LDR | unmatched | 0.846 |
Hamann L | 2014 | Germany | Caucasian | Population | 206 | 200 | 12 | 74 | 120 | 10 | 73 | 117 | PCR-HRM | unmatched | 0.748 |
Chen L | 2013 | China | Asian | Hospital | 658 | 658 | 172 | 305 | 181 | 134 | 330 | 194 | Taqman | matched | 0.769 |
Yang Y-a | 2012 | China | Asian | Population | 853 | 948 | 272 | 392 | 165 | 271 | 457 | 189 | Taqman | matched | 0.885 |
Li L | 2012 | China | Asian | Hospital | 415 | 1010 | 149 | 184 | 82 | 345 | 455 | 210 | PCR-RFLP | unmatched | 0.009 |
microRNA-196a2 rs11614913 T>C | CC | TC | TT | CC | TC | TT | |||||||||
Sung JH | 2016 | Korea | Korean | Hospital | 522 | 535 | 107 | 236 | 179 | 108 | 274 | 153 | PCR-RFLP | matched | 0.465 |
Huang SL | 2015 | China | Asian | Hospital | 722 | 721 | 147 | 381 | 190 | 156 | 360 | 204 | Taqman | matched | 0.905 |
Xiong XD | 2014 | China | Asian | Hospital | 295 | 283 | 78 | 131 | 86 | 68 | 132 | 83 | PCR-RFLP | unmatched | 0.278 |
Chen CR | 2014 | China | Asian | Hospital | 919 | 889 | 157 | 450 | 312 | 161 | 406 | 322 | PCR-LDR | unmatched | 0.097 |
Zhi H | 2012 | China | Asian | Hospital | 916 | 584 | 155 | 470 | 291 | 98 | 278 | 208 | PCR-RFLP | matched | 0.755 |
Yang Y-a | 2012 | China | Asian | Population | 853 | 948 | 163 | 463 | 202 | 217 | 463 | 241 | Taqman | matched | 0.853 |
Yang Y-b | 2012 | China | Asian | Population | 1919 | 1840 | 433 | 971 | 493 | 389 | 921 | 528 | Taqman | matched | 0.734 |
microRNA-499 rs3746444 G>A | GG | AG | AA | GG | AG | AA | |||||||||
Sung JH | 2016 | Korea | Korean | Hospital | 522 | 535 | 9 | 155 | 358 | 13 | 168 | 354 | PCR-RFLP | matched | 0.182 |
Xiong XD | 2014 | China | Asian | Hospital | 295 | 283 | 3 | 65 | 227 | 4 | 67 | 212 | PCR-RFLP | unmatched | 0.616 |
Chen CR | 2014 | China | Asian | Hospital | 919 | 889 | 70 | 237 | 612 | 37 | 246 | 606 | PCR-LDR | unmatched | 0.062 |
Chen L | 2013 | China | Asian | Hospital | 658 | 658 | 46 | 149 | 463 | 26 | 158 | 474 | Taqman | matched | 0.007 |
Zhi H | 2012 | China | Asian | Hospital | 916 | 584 | 86 | 201 | 629 | 21 | 167 | 396 | PCR-RFLP | matched | 0.517 |
Yang Y-a | 2012 | China | Asian | Population | 853 | 948 | 28 | 210 | 589 | 28 | 212 | 683 | Taqman | matched | 0.023 |
microRNA-149 rs71428439 G>A | GG | AG | AA | GG | AG | AA | |||||||||
Chen CR | 2014 | China | Asian | Hospital | 919 | 889 | 155 | 389 | 375 | 124 | 381 | 384 | PCR-LDR | unmatched | 0.062 |
Ding SL | 2013 | China | Asian | NA | 289 | 296 | 64 | 130 | 95 | 38 | 126 | 132 | PCR-DNA sequencing | matched | 0.360 |
CHD: coronary heart disease. HWE: Hardy-Weinberg equilibrium. a HWE in control. NA: not available